Addex Therapeutics: Implications of Transporter Regulatory Themes in Drug Development

Hosted By: Niamh Madigan
Rate this Podcast: 
Average: 4.5 (2 votes)
To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

About this Podcast...

Sonia Poli, VP for Non Clinical Development at Addex Therapeutics, a small biotech built in Geneva explains how the new FDA and EMA guidelines will impact their business. She looks at the daily challenges they are faced with  and stresses the importance of having highly valuated assays which will translate into clinical data.


Have Your Say
Rate this feature and give us your feedback in the comments section below


Crowne Plaza Zurich, Zurich, Switzerland
June 17 - 19, 2018